Luna, Carlos M.
Pulido, Laura
Niederman, Michael S.
Casey, Alberto
Burgos, Diego
Leiva Agüero, Sebastián D.
Grosso, Alejandra
Membriani, Evangelina
Entrocassi, Andrea C.
Rodríquez Fermepin, Marcelo
Vay, Carlos A.
Garcia, Susana
Famiglietti, Angela
Funding for this research was provided by:
Cooperadora del Hospital de Clínicas (Non Available)
Ministry of Education, Secretaría de Ciencia y Técnica, University of Buenos Aires (Non Available)
Article History
Received: 2 May 2018
Accepted: 16 August 2018
First Online: 25 September 2018
Ethics approval and consent to participate
: This study was approved by the ethics committee “Comité de Etica del Hospital de Clínicas, Coordinator Dr. Carlos Tealdi”, patient-informed consent was waived because of the observational nature of the study, but the study team explained the potential risks related to drawing blood, including the nature of potential risk of blood drawing.
: Dr. Luna reports personal fees from Pfizer and personal fees from Merk Sharp Dohne, outside the submitted work. Dr. Pulido, Dr. Niederman, Dr. Casey, Dr. Burgos1, Dr. Leiva Agüero, Dr. Grosso1, Dr. Membriani, Dr. Entrocassi, Dr. Rodríquez Fermepin, Dr. Vay1, Dr. Garcia, and Dr. Famiglietti, have no competing interests to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.